An implantable lens made of a biocompatible collagen copolymer was found safe and effective for myopia in a study of long-term outcomes published in the July issue of the Archives of Ophthalmology.
The Food and Drug Administration announced July 10 that it had approved the antiplatelet agent prasugrel to reduce the risk of clotting during percutaneous coronary intervention.
Nearly 20% of Medicare patients who are admitted to the hospital after an acute myocardial infarction will be readmitted within 30 days, according to historical data released July 9 by the Centers for Medicare and Medicaid Services.
Bevacizumab, a vascular endothelial growth factorneutralizing antibody, reduced the volume of vestibular schwannomas and/or improved hearing loss in 6 of 10 patients with neurofibromatosis type 2, according to a report in the July 23 issue of the New England Journal of Medicine.
To reduce the risk of fatal propoxyphene overdoses, the Food and Drug Administration is mandating that manufacturers of propoxyphene-containing pain products add risk information to the boxed warning in product labels. The agency also is requiring manufacturers to conduct a new study on the cardiac safety of the drug at higher than recommended doses.
A cognitive-behavioral intervention delivered via the Internet significantly reduced insomnia severity and contributed to overall sleep improvement in a study of 44 patients, according to a report in the July issue of the Archives of General Psychiatry.
The Program Committee history is now available. There is information on MDMLG Programs going back to the 1999-2000 fiscal year. http://www.mdmlg.org/program-history.htm (Source: MDMLG / Metropolitan Detroit Medical Library Group)
